A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)

BACKGROUND: Lung adenocarcinoma (LUAD) is one of the most common types in the world with a high mortality rate. Despite advances in treatment strategies, the overall survival (OS) remains short. Our study aims to establish a reliable prognostic signature closely related to the survival of LUAD patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Dherasi, Aisha, Huang, Qi-Tian, Liao, Yuwei, Al-Mosaib, Sultan, Hua, Rulin, Wang, Yichen, Yu, Ying, Zhang, Yu, Zhang, Xuehong, Huang, Chao, Mousa, Haithm, Ge, Dongcen, Sufiyan, Sufiyan, Bai, Wanting, Liu, Ruimei, Shao, Yanyan, Li, Yulong, Zhang, Jingkai, Shi, Leming, Lv, Dekang, Li, Zhiguang, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183047/
https://www.ncbi.nlm.nih.gov/pubmed/34092242
http://dx.doi.org/10.1186/s12935-021-01975-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183047/
https://www.ncbi.nlm.nih.gov/pubmed/34092242
http://dx.doi.org/10.1186/s12935-021-01975-z

Ejemplares similares